During the past decade, Lynchburg Pulmonary Associates conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lynchburg Pulmonary Associates" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Lynchburg Pulmonary Associates" are "COPD" (1 trials), "Idiopathic Pulmonary Fibrosis" (1 trials), "Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease" (1 trials), "Lung Diseases, Obstructive" (1 trials) and "Persistent Allergic Asthma" (1 trials). Many other conditions were trialed in "Lynchburg Pulmonary Associates" in a lesser frequency.

Most popular intervention types in "Lynchburg Pulmonary Associates" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Formoterol (12 µg b.i.d.)" (1 trials), "Indacaterol" (1 trials), "Nintedanib" (1 trials), "Omalizumab" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lynchburg Pulmonary Associates" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Lynchburg Pulmonary Associates". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Lynchburg Pulmonary Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Lynchburg Pulmonary Associates, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".